NOV 2, 2026 · JOURNAL ARTICLE
Metabolic reprogramming in PTSD: GLP-1 receptor agonists and cardiometabolic drug repurposing for precision therapeutics
Frontiers in Behavioral Neuroscience
Post-traumatic stress disorder (PTSD) is increasingly recognized as a systemic disorder closely linked to metabolic dysfunction, including obesity, insulin resistance, type 2 diabe